Quince Therapeutics, Inc.
USD1.03
-0.02 (-1.90%)
CEO
Dirk Thye
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.07
Prev. Close
$1.05
Day Low
$1.00
Day High
$1.07
52W Low
$0.79
52W High
$45.50
Market Cap
$0.01B
Volume
1.10M
| 200,000 |
| $3.08 |
| 23 Jan 2026 | Hannah Brendan | CBO, COO & CCO | A-Award | Disposed | 365,000 | $3.08 |
| 21 Jan 2026 | Senner Christopher J. | director | A-Award | Acquired | 21,810 | $3.00 |
| 21 Jan 2026 | McLoughlin Margaret | director | A-Award | Acquired | 19,547 | $3.00 |
| 21 Jan 2026 | Lamond David | director | A-Award | Acquired | 29,423 | $3.00 |
| 21 Jan 2026 | Bray June | director | A-Award | Acquired | 18,724 | $3.00 |
| 29 Dec 2025 | Benatti Luca | director | S-Sale | Disposed | 50,000 | $3.47 |
| 29 Dec 2025 | Benatti Luca | director | J-Other | Acquired | 8,918 | $0.00 |
| 12 Dec 2025 | Thye Dirk | director, officer: CEO and CMO | G-Gift | Disposed | 739,885 | $0.00 |